Tower Research Capital (TRC)’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.63M | Buy |
71,534
+61,199
| +592% | +$2.25M | 0.07% | 249 |
|
|
2025
Q1 | $365K | Sell |
10,335
-8,144
| -44% | -$288K | 0.01% | 1029 |
|
|
2024
Q4 | $808K | Buy |
18,479
+16,087
| +673% | +$704K | 0.02% | 744 |
|
|
2024
Q3 | $108K | Sell |
2,392
-23,662
| -91% | -$1.07M | ﹤0.01% | 2159 |
|
|
2024
Q2 | $1.01M | Buy |
26,054
+24,641
| +1,744% | +$956K | 0.02% | 766 |
|
|
2024
Q1 | $45.5K | Sell |
1,413
-7,132
| -83% | -$230K | ﹤0.01% | 2344 |
|
|
2023
Q4 | $245K | Sell |
8,545
-12,146
| -59% | -$348K | ﹤0.01% | 1935 |
|
|
2023
Q3 | $573K | Buy |
20,691
+17,746
| +603% | +$491K | 0.02% | 798 |
|
|
2023
Q2 | $78.8K | Sell |
2,945
-473
| -14% | -$12.7K | ﹤0.01% | 2208 |
|
|
2023
Q1 | $74K | Buy |
3,418
+1,481
| +76% | +$32.1K | ﹤0.01% | 2152 |
|
|
2022
Q4 | $46K | Sell |
1,937
-4,014
| -67% | -$95.3K | ﹤0.01% | 2418 |
|
|
2022
Q3 | $117K | Sell |
5,951
-368
| -6% | -$7.24K | ﹤0.01% | 2436 |
|
|
2022
Q2 | $123K | Sell |
6,319
-1,120
| -15% | -$21.8K | ﹤0.01% | 2125 |
|
|
2022
Q1 | $190K | Sell |
7,439
-44
| -0.6% | -$1.12K | ﹤0.01% | 1765 |
|
|
2021
Q4 | $188K | Buy |
7,483
+1,417
| +23% | +$35.6K | ﹤0.01% | 1818 |
|
|
2021
Q3 | $167K | Buy |
6,066
+1,847
| +44% | +$50.8K | ﹤0.01% | 1978 |
|
|
2021
Q2 | $134K | Buy |
4,219
+2,176
| +107% | +$69.1K | ﹤0.01% | 2193 |
|
|
2021
Q1 | $94K | Sell |
2,043
-1,820
| -47% | -$83.7K | ﹤0.01% | 2636 |
|
|
2020
Q4 | $153K | Sell |
3,863
-6,384
| -62% | -$253K | ﹤0.01% | 1959 |
|
|
2020
Q3 | $357K | Buy |
10,247
+7,420
| +262% | +$259K | ﹤0.01% | 2025 |
|
|
2020
Q2 | $89K | Buy |
+2,827
| New | +$89K | ﹤0.01% | 2561 |
|